Skip to Main content Skip to Navigation
Journal articles

Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology

Sandro Alves 1 Guillaume Churlaud 2 David Klatzmann 3 Nathalie Cartier 1
1 U 1169 - Thérapie génique, Génomique et Epigénomique
2 DHU - I2B - Departement Hospitalo- Universitaire - Inflammation, Immunopathologie, Biothérapie [Paris]
3 Service de biothérapies [CHU Pitié-Salpétrière]
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-01617417
Contributor : David Klatzmann Connect in order to contact the contributor
Submitted on : Monday, October 16, 2017 - 3:24:08 PM
Last modification on : Thursday, December 10, 2020 - 3:44:04 AM

Links full text

openaccess

Identifiers

Collections

INSERM | CEA | UPMC | CEA-UPSAY | SORBONNE-UNIVERSITE | SU-MEDECINE | SU-TI

`

Citation

Sandro Alves, Guillaume Churlaud, David Klatzmann, Nathalie Cartier. Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology. Brain - A Journal of Neurology , Oxford University Press (OUP), 2017, 140 (7), pp.e40 - e40. ⟨10.1093/brain/awx109⟩. ⟨inserm-01617417⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

170